Compare · INNV vs OPCH
INNV vs OPCH
Side-by-side comparison of InnovAge Holding Corp. (INNV) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INNV and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.54B, about 2.4x INNV ($1.48B).
- INNV has hit the wire 3 times in the past 4 weeks while OPCH has been quiet.
- OPCH has more recent analyst coverage (17 ratings vs 16 for INNV).
- Company
- InnovAge Holding Corp.
- Option Care Health Inc.
- Price
- -
- -
- Market cap
- $1.48B
- $3.54B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 16
- 17
InnovAge Holding Corp.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, dental, mental health and psychiatric, meals, and activities, as well as physical, occupational, and speech therapy; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,600 PACE participants in the United States of America; and operates seventeen PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest INNV
- InnovAge upgraded by KeyBanc Capital Markets with a new price target
- New insider Taheri Paul claimed ownership of 38,765 shares (SEC Form 3)
- SEC Form EFFECT filed by InnovAge Holding Corp.
- SEC Form S-3 filed by InnovAge Holding Corp.
- CHIEF EXECUTIVE OFFICER Blair Patrick T was granted 78,397 shares, increasing direct ownership by 12% to 751,047 units (SEC Form 4)
- CHIEF FINANCIAL OFFICER Adams Benjamin C was granted 17,123 shares (SEC Form 4)
- CHIEF LEGAL OFFICER Damato Nicole was granted 51,369 shares, increasing direct ownership by 19% to 328,711 units (SEC Form 4)
- Chief Administrative Officer Delk Meredith was granted 42,808 shares (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 14,453 shares, decreasing direct ownership by 2% to 672,650 units (SEC Form 4) to cover withholding tax
- CHIEF LEGAL OFFICER Damato Nicole covered exercise/tax liability with 19,401 shares, decreasing direct ownership by 7% to 277,342 units (SEC Form 4) (tax withholding)
Latest OPCH
- Option Care Health downgraded by Deutsche Bank with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations